Population
Streptomyces galilaeus aclacinomycin-negative mutant strain KE303
Design
Preclinical
Authors
Loading...
Specifies viable aglycones for anthracycline synthesis; leaves open clinical translation from this level-5 animal study.
The study elucidates the step-wise biosynthesis of aclacinomycin A from aklavinone via aklavin and MA144 S1 using a mutant Streptomyces strain.
OKI et al. (1980) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: